Jumpcode Genomics
PrivateLast Round
Grant
Feb 20, 2025
Total Funding Raised
$37.39M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Jumpcode Genomics is a biotechnology company that develops and commercializes CRISPR-based technology for next-generation sequencing (NGS) to improve data sensitivity and simplify workflows.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jumpcode Genomics Comparables
Compare Jumpcode Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| siTOOLs Biotech GmbH | 84% | |
| Watchmaker Genomics | 81% | |
| Lexogen | 79% | |
Jumpcode Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2025 | ||||
| VC Round | Aug 21, 2024 | ||||
| Series B Extension | Apr 27, 2023 | ||||
| VC Round | Sep 21, 2022 | ||||
| Series B | Jan 12, 2021 | ||||
Series A | Feb 11, 2020 |
Key People
Founding team and executive leadership
Jumpcode Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LYZZ Capital | Series B, Seed |
| Arboretum Ventures | Series B |
| Baird Capital | Series B |
| European Health and Digital Executive Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 68% MoM, reaching 1.4K.
- Apr 27, 2023
Raised $9.19M in a Series B Extension round.
Jumpcode Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Jumpcode Genomics's valuation, stock price, and market status.